These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38890811)
41. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs. Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008 [TBL] [Abstract][Full Text] [Related]
42. Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. Smallwood K; Harper A; Blackwood L J Feline Med Surg; 2021 Aug; 23(8):722-729. PubMed ID: 33176543 [TBL] [Abstract][Full Text] [Related]
43. CCNU in the treatment of canine epitheliotropic lymphoma. Williams LE; Rassnick KM; Power HT; Lana SE; Morrison-Collister KE; Hansen K; Johnson JL J Vet Intern Med; 2006; 20(1):136-43. PubMed ID: 16496933 [TBL] [Abstract][Full Text] [Related]
44. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
45. Multicentric canine lymphoma in a 12-year-old keeshond: chemotherapy options. Martineau MM Can Vet J; 2002 Sep; 43(9):709-11. PubMed ID: 12240530 [TBL] [Abstract][Full Text] [Related]
46. Influence of asparaginase on a combination chemotherapy protocol for canine multicentric lymphoma. Jeffreys AB; Knapp DW; Carlton WW; Thomas RM; Bonney PL; Degortari A; Lucroy MD J Am Anim Hosp Assoc; 2005; 41(4):221-6. PubMed ID: 15995158 [TBL] [Abstract][Full Text] [Related]
47. Treatment of feline gastrointestinal intermediate- or large-cell lymphoma with lomustine chemotherapy and 8 Gy abdominal cavity radiation therapy. Gieger TL; Seiler GS; Nolan MW J Feline Med Surg; 2021 Jun; 23(6):469-476. PubMed ID: 32996835 [TBL] [Abstract][Full Text] [Related]
48. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs. Rassnick KM; Bailey DB; Malone EK; Intile JL; Kiselow MA; Flory AB; Barlow LL; Balkman CE; Barnard SM; Waite AH Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406 [TBL] [Abstract][Full Text] [Related]
49. Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study. Bavcar S; de Vos J; Kessler M; de Fornel P; Buracco P; Murphy S; Hirschberger J; Argyle DJ Vet J; 2017 Jun; 224():1-6. PubMed ID: 28697868 [TBL] [Abstract][Full Text] [Related]
50. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link? Wang SL; Lee JJ; Liao AT Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922 [TBL] [Abstract][Full Text] [Related]
51. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma. Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445 [TBL] [Abstract][Full Text] [Related]
52. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma. Burton JH; Garrett-Mayer E; Thamm DH Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975 [TBL] [Abstract][Full Text] [Related]
53. Comparison of a CHOP-LAsp-based protocol with and without maintenance for canine multicentric lymphoma. Lautscham EM; Kessler M; Ernst T; Willimzig L; Neiger R Vet Rec; 2017 Mar; 180(12):303. PubMed ID: 28100766 [TBL] [Abstract][Full Text] [Related]
54. Sequential low-dose rate half-body irradiation and chemotherapy for the treatment of canine multicentric lymphoma. Lurie DM; Gordon IK; Théon AP; Rodriguez CO; Suter SE; Kent MS J Vet Intern Med; 2009; 23(5):1064-70. PubMed ID: 19627472 [TBL] [Abstract][Full Text] [Related]
56. OUTCOME OF DOGS WITH INTRANASAL LYMPHOMA TREATED WITH VARIOUS RADIATION AND CHEMOTHERAPY PROTOCOLS: 24 CASES. George R; Smith A; Schleis S; Brawner W; Almond G; Kent M; Wypij J; Borrego J; Moore A; Keyerleber M; Kraiza S Vet Radiol Ultrasound; 2016 May; 57(3):306-12. PubMed ID: 26763938 [TBL] [Abstract][Full Text] [Related]
57. Hematological and blood biochemistry parameters as prognostic indicators of survival in canine multicentric lymphoma treated with COP and L-COP protocols. Sutthigran S; Saisawart P; Teewasutrakul P; Sirivisoot S; Thanaboonnipat C; Rungsipipat A; Choisunirachon N Vet World; 2024 Feb; 17(2):344-355. PubMed ID: 38595652 [TBL] [Abstract][Full Text] [Related]
58. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers. Elliott J Aust Vet J; 2018 Dec; 96(12):502-507. PubMed ID: 30478839 [TBL] [Abstract][Full Text] [Related]
59. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821 [TBL] [Abstract][Full Text] [Related]
60. Maintenance treatment in relapsed canine lymphoma after a short L-CHOP protocol. Troedson K; Ignatenko N; Fejos C; Zablotski Y; Hirschberger J Tierarztl Prax Ausg K Kleintiere Heimtiere; 2021 Jun; 49(3):185-194. PubMed ID: 34157760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]